| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3827828 | Revista Clínica Española | 2011 | 8 Pages |
Abstract
Under standard clinical practice conditions, ezetimibe appears to be effective and safe for the control LDLc, thus making it possible to reach the therapeutic objectives proposed by the ATP-III in a high number of patients, especially when associated to statins.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
J.L. DÃaz DÃaz, M. Suárez Tembra, J.A. DÃaz Peromingo, M. Pena Seijo, T. MartÃnez Ramonde, A. Pose Reino,